Clinical trial BE-QUALMS
A Multicenter observational Belgian study assessing the impact of newly started treatment on the QOL in patients suffering from myelodysplastic syndromes
| Cancers | |
|---|---|
| Organ | Blood |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Prospective observational study
|
| Phase | Trial phase 4 |
| Academic trial | Non |
| BECT Identifier | B300201938708 |
| Inclusion criteria | - Newly diagnosed patients with myelodysplastic syndromes defined by WHO 2016 criteria that are about to start treatment.- Patients with a known diagnosis of MDS, irrespective of IPSS and irrespective of time of diagnosis that are about to start a new th |
| Last update |